3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide

C128H131F6N23O15S — CID 157200060

IUPAC3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide
SMILESCOCC1CCCN1c1ncc(-c2nc(-c3cc(F)ccc3OC)no2)cc1C.COc1ccc(F)cc1-c1noc(-c2ccc(-c3cccnc3C)c(C)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(C#N)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(NS(C)(=O)=O)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)nc2)n1.COc1ccc(F)cc1-c1noc(-c2cnc(N3CCCCC3C)c(C)c2)n1
InChIInChI=1S/C22H25FN4O4S.C22H21FN4O2.C22H18FN3O2.C21H23FN4O3.C21H23FN4O2.C20H21FN4O2/c1-14-6-4-5-11-27(14)19-9-7-15(12-18(19)26-32(3,28)29)22-24-21(25-31-22)17-13-16(23)8-10-20(17)30-2;1-14-5-3-4-10-27(14)19-8-6-15(11-16(19)13-24)22-25-21(26-29-22)18-12-17(23)7-9-20(18)28-2;1-13-11-15(6-8-17(13)18-5-4-10-24-14(18)2)22-25-21(26-28-22)19-12-16(23)7-9-20(19)27-3;1-13-9-14(11-23-20(13)26-8-4-5-16(26)12-27-2)21-24-19(25-29-21)17-10-15(22)6-7-18(17)28-3;1-13-10-15(12-23-20(13)26-9-5-4-6-14(26)2)21-24-19(25-28-21)17-11-16(22)7-8-18(17)27-3;1-13-5-3-4-10-25(13)18-9-6-14(12-22-18)20-23-19(24-27-20)16-11-15(21)7-8-17(16)26-2/h7-10,12-14,26H,4-6,11H2,1-3H3;6-9,11-12,14H,3-5,10H2,1-2H3;4-12H,1-3H3;6-7,9-11,16H,4-5,8,12H2,1-3H3;7-8,10-12,14H,4-6,9H2,1-3H3;6-9,11-13H,3-5,10H2,1-2H3
InChIKeyAQRRVAUJDUSFRG-UHFFFAOYSA-N
MW2377.66 g/mol
LogP27.16
Rot. Bonds28

About 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide

3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide (PubChem CID 157200060) has the molecular formula C128H131F6N23O15S and a molecular weight of 2377.66 g/mol. Its IUPAC name is 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide.

Molecular Properties

Compound Name3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide
PubChem CID157200060
Molecular FormulaC128H131F6N23O15S
Molecular Weight2377.66 g/mol
Exact Mass2375.98
IUPAC Name3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide
SMILESCOCC1CCCN1c1ncc(-c2nc(-c3cc(F)ccc3OC)no2)cc1C.COc1ccc(F)cc1-c1noc(-c2ccc(-c3cccnc3C)c(C)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(C#N)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(NS(C)(=O)=O)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)nc2)n1.COc1ccc(F)cc1-c1noc(-c2cnc(N3CCCCC3C)c(C)c2)n1
InChIInChI=1S/C22H25FN4O4S.C22H21FN4O2.C22H18FN3O2.C21H23FN4O3.C21H23FN4O2.C20H21FN4O2/c1-14-6-4-5-11-27(14)19-9-7-15(12-18(19)26-32(3,28)29)22-24-21(25-31-22)17-13-16(23)8-10-20(17)30-2;1-14-5-3-4-10-27(14)19-8-6-15(11-16(19)13-24)22-25-21(26-29-22)18-12-17(23)7-9-20(18)28-2;1-13-11-15(6-8-17(13)18-5-4-10-24-14(18)2)22-25-21(26-28-22)19-12-16(23)7-9-20(19)27-3;1-13-9-14(11-23-20(13)26-8-4-5-16(26)12-27-2)21-24-19(25-29-21)17-10-15(22)6-7-18(17)28-3;1-13-10-15(12-23-20(13)26-9-5-4-6-14(26)2)21-24-19(25-28-21)17-11-16(22)7-8-18(17)27-3;1-13-5-3-4-10-25(13)18-9-6-14(12-22-18)20-23-19(24-27-20)16-11-15(21)7-8-17(16)26-2/h7-10,12-14,26H,4-6,11H2,1-3H3;6-9,11-12,14H,3-5,10H2,1-2H3;4-12H,1-3H3;6-7,9-11,16H,4-5,8,12H2,1-3H3;7-8,10-12,14H,4-6,9H2,1-3H3;6-9,11-13H,3-5,10H2,1-2H3
InChIKeyAQRRVAUJDUSFRG-UHFFFAOYSA-N
XLogP27.16
TPSA435.85 Ų
H-Bond Donors1
H-Bond Acceptors37
Rotatable Bonds28
Heavy Atoms173
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002377.66
LogP ≤ 527.16
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1037

Analyze 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide?
The IUPAC name of 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide (CID 157200060) is 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide.
What is the SMILES notation for 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide?
The canonical SMILES for 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide is COCC1CCCN1c1ncc(-c2nc(-c3cc(F)ccc3OC)no2)cc1C.COc1ccc(F)cc1-c1noc(-c2ccc(-c3cccnc3C)c(C)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(C#N)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(NS(C)(=O)=O)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)nc2)n1.COc1ccc(F)cc1-c1noc(-c2cnc(N3CCCCC3C)c(C)c2)n1.
What is the InChIKey of 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide?
The InChIKey is AQRRVAUJDUSFRG-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25FN4O4S.C22H21FN4O2.C22H18FN3O2.C21H23FN4O3.C21H23FN4O2.C20H21FN4O2/c1-14-6-4-5-11-27(14)19-9-7-15(12-18(19)26-32(3,28)29)22-24-21(25-31-22)17-13-16(23)8-10-20(17)30-2;1-14-5-3-4-10-27(14)19-8-6-15(11-16(19)13-24)22-25-21(26-29-22)18-12-17(23)7-9-20(18)28-2;1-13-11-15(6-8-17(13)18-5-4-10-24-14(18)2)22-25-21(26-28-22)19-12-16(23)7-9-20(19)27-3;1-13-9-14(11-23-20(13)26-8-4-5-16(26)12-27-2)21-24-19(25-29-21)17-10-15(22)6-7-18(17)28-3;1-13-10-15(12-23-20(13)26-9-5-4-6-14(26)2)21-24-19(25-28-21)17-11-16(22)7-8-18(17)27-3;1-13-5-3-4-10-25(13)18-9-6-14(12-22-18)20-23-19(24-27-20)16-11-15(21)7-8-17(16)26-2/h7-10,12-14,26H,4-6,11H2,1-3H3;6-9,11-12,14H,3-5,10H2,1-2H3;4-12H,1-3H3;6-7,9-11,16H,4-5,8,12H2,1-3H3;7-8,10-12,14H,4-6,9H2,1-3H3;6-9,11-13H,3-5,10H2,1-2H3.
What are the key properties of 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide?
3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide has a molecular weight of 2377.66 g/mol, XLogP of 27.16, 28 rotatable bonds, 1 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(5-fluoro-2-methoxyphenyl)-5-[6-[2-(methoxymethyl)pyrrolidin-1-yl]-5-methyl-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide is sourced from PubChem (CID 157200060), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).